The symposium brings together leaders from science, medicine, technology, and policy. Together, they will explore the state of AI in biomedicine and what it will take to deploy these technologies responsibly to advance discovery, support clinicians, and improve patient health.

This year’s program will feature conversations with leading voices shaping the field, including Bob Wachter, Chair of Medicine at UCSF, and Nate Gross, VP of Health at OpenAI.